No Prescription » Prescription Drugs 8 » Genox Nolvadex
This medication is used to: treat breast cancer that has spread to other parts of the body in men and women. treat early breast cancer in women who have already been treated with surgery radiation and/or chemotherapy. reduce the risk of developing a more serious type of breast cancer in women who have had ductal carcinoma in situ (DCIS; a type of breast cancer that does not spread outside of the milk duct where it forms) and who have been treated with surgery and radiation. reduce the risk of breast cancer in women who are at high risk for the disease due to their age personal medical history and family medical history. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow.Tamoxifen is usually taken once or twice a day with or without food. Take tamoxifen at around the same time(s) every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain anything you do not understand. Take tamoxifen exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow tamoxifen tablets whole; do not split chew or crush them. Swallow the tablets with water or any other nonalcoholic drink.If you are taking tamoxifen to prevent breast cancer you will probably take it for five years. If you are taking tamoxifen to treat breast cancer your doctor will decide how long your treatment will last. Do not stop taking tamoxifen without talking to your doctor.If you forget to take a dose of tamoxifen take the missed dose as soon as you remember it and take your next dose as usual. However if it is almost time for your next dose skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.Other uses for this medicine Tamoxifen is also used sometimes to induce ovulation (egg production) in women who do not produce eggs but wish to become pregnant. Tamoxifen is also sometimes used to treat McCune-Albright syndrome (a condition that may cause bone disease early sexual development and dark colored spots on the skin in children). Talk to your doctor about the possible risks of using this drug for your condition.
Buy Genox Nolvadex and other Prescription Drugs 8 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Genox Nolvadex:
Product Type: Prescription Drugs 8
Genox ( Nolvadex Generic Tamoxifen )
Genox (Nolvadex Generic Tamoxifen)
Nolvadex Generic Tamoxifen
10mg 20mg 30 tabs 40 tabs 100 tabs
Nolvadex Generic Tamoxifen Genox

View more
Prescription Drugs 8
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|